{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:56:33Z","timestamp":1782280593626,"version":"3.54.5"},"posted":{"date-parts":[[2025,6,3]]},"group-title":"Cancer Biology","reference-count":69,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["DK042191"],"award-info":[{"award-number":["DK042191"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["DK091222"],"award-info":[{"award-number":["DK091222"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["DK055812"],"award-info":[{"award-number":["DK055812"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["DK097948"],"award-info":[{"award-number":["DK097948"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Colitis-associated cancer (CAC) arises from a complex interplay between host and environmental factors, including the gut microbiome. Since ulcerative colitis (UC), a significant risk factor for CAC, is rising in prevalence worldwide, an integrative approach is essential to identify potential triggers linking inflammation to cancer. In the present study, we investigated the role of the gut microbiome using Winnie mice, a UC-like model with a relevant missense mutation in the\n                  <jats:italic>Muc2 gene.<\/jats:italic>\n                  Upon transfer from a conventional (CONV) to a specific-pathogen-free (SPF) facility, Winnie mice exhibited a more severe colitis phenotype, and notably, spontaneous CAC as early as four weeks of age, which progressively worsened over time. In contrast, CONV Winnie developed only mild colitis but with no overt signs of tumorigenesis. Notably, when rederived into germ-free (GF) conditions, SPF Winnie mice were protected from colitis or colon tumor development, indicating an essential role for the gut microbiome in the initiation and progression of CAC in these mice. Using shotgun metagenomics, metabolomics, and lipidomics, we identified a distinct pro-inflammatory microbial and metabolic signature that potentially drives the transition from colitis to CAC. Fecal microbiota transplantation (FMT), using either SPF Winnie or WT (Bl\/6) donors into GF Winnie recipients, demonstrated that while colitis developed regardless of donor, only FMT from SPF Winnie donors resulted in CAC, revealing a microbiota-driven, host-specific susceptibility to tumorigenesis in Winnie mice. Our studies present a novel and relevant model of CAC, providing further evidence that the microbiome plays a key role in the pathogenesis of CAC, thereby challenging the concept of colon cancer as a strictly non-transmissible disease.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Lay summary<\/jats:title>\n                  <jats:p>This study reveals a distinct metagenomic, metabolomic, and lipidomic profile associated with tumorigenesis in a murine model of ulcerative colitis, highlighting the risks of specific intestinal dysbiosis in genetically predisposed subjects.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>What you need to know<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and context<\/jats:title>\n                    <jats:p>Colitis-associated colorectal cancer arises from complex host-environment interactions, including gut microbiome influences, driving chronic inflammation, with the intestinal lumen environment remaining a largely unexplored potential risk factor in cancer development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>New findings<\/jats:title>\n                    <jats:p>Winnie mice in specific pathogen-free conditions developed severe colitis, and a novel juvenile colon dysplasia and cancer, with gut microbiome changes driving colitis-associated cancer initiation and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>We identified a pro-inflammatory microbial\/metabolic signature promoting colitis-to-CAC transition in Winnie mice, with FMT confirming microbiota-driven tumor susceptibility. However, further research is needed to pinpoint the key bacteria-metabolite-lipid combination driving CAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical research relevance<\/jats:title>\n                    <jats:p>This newly characterized microbiota-metabolome-based model of CAC, challenges the dogma of cancer as a non-transmittable disease, providing a foundation for developing microbiota-based strategies for CAC prevention and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Basic research relevance<\/jats:title>\n                    <jats:p>Unlike genetic or chemically induced models, the Winnie mouse model uniquely serves as a dual model for spontaneous colitis and juvenile CAC, offering a fast, 100% penetrant phenotype that enhances reliability, accelerates research, and provides valuable insights into IBD and CAC.<\/jats:p>\n                  <\/jats:sec>\n                <\/jats:sec>","DOI":"10.1101\/2025.05.31.657160","type":"posted-content","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:16:58Z","timestamp":1749014218000},"source":"Crossref","is-referenced-by-count":0,"title":["A missense mutation in\n                  <i>Muc2<\/i>\n                  promotes gut microbiome- and metabolome-dependent colitis-associated tumorigenesis"],"prefix":"10.64898","author":[{"given":"Giulio","family":"Verna","sequence":"first","affiliation":[{"name":"Department of Medicine, Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"De Santis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Sommella","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Licastro","sequence":"additional","affiliation":[{"name":"AREA Science Park, Padriciano, 34149, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Population & Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano","family":"De Almeida Celio","sequence":"additional","affiliation":[{"name":"Department of Medicine, Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Merciai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Caponigro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Campiglia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa T.","family":"Pizarro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Chieppa","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine (DiMeS), University of Salento, 73100 Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-1548","authenticated-orcid":false,"given":"Fabio","family":"Cominelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Digestive Health Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026041201071001000_2025.05.31.657160v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00966-2"},{"key":"2026041201071001000_2025.05.31.657160v1.2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828029c0"},{"key":"2026041201071001000_2025.05.31.657160v1.3","first-page":"53","article-title":"Current management of inflammatory bowel disease and colorectal cancer","volume":"4","year":"2011","journal-title":"Gastrointest Cancer Res"},{"key":"2026041201071001000_2025.05.31.657160v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.13"},{"key":"2026041201071001000_2025.05.31.657160v1.5","doi-asserted-by":"crossref","unstructured":"Chieppa M , De Santis S , Verna G . Winnie Mice: A Chronic and Progressive Model of Ulcerative Colitis. Inflamm Bowel Dis 2025:izaf006.","DOI":"10.1093\/ibd\/izaf006"},{"key":"2026041201071001000_2025.05.31.657160v1.6","doi-asserted-by":"crossref","unstructured":"Hou K , Wu Z-X , Chen X-Y , et al. Microbiota in health and diseases. Signal Transduct Target Ther 2022;7:135.","DOI":"10.1038\/s41392-022-00974-4"},{"key":"2026041201071001000_2025.05.31.657160v1.7","doi-asserted-by":"crossref","unstructured":"De Santis S , Liso M , Vacca M , et al. Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects. Cancers (Basel) 2021;13.","DOI":"10.3390\/cancers13020283"},{"key":"2026041201071001000_2025.05.31.657160v1.8","doi-asserted-by":"crossref","unstructured":"Li J , Zhang A , Wu F , et al. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Front Oncol 2022;12. Available at: https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2022.841552\/full [Accessed February 1, 2025].","DOI":"10.3389\/fonc.2022.841552"},{"key":"2026041201071001000_2025.05.31.657160v1.9","doi-asserted-by":"crossref","unstructured":"Verna G , Liso M , Cavalcanti E , et al. Deletion of TNF in Winnie-APCMin\/+ Mice Reveals Its Dual Role in the Onset and Progression of Colitis-Associated Colorectal Cancer. Int J Mol Sci 2022;23:15145.","DOI":"10.3390\/ijms232315145"},{"key":"2026041201071001000_2025.05.31.657160v1.10","first-page":"2368","article-title":"Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-n\u2019-nitro-N-nitrosoguanidine","volume":"34","year":"1974","journal-title":"Cancer Res"},{"key":"2026041201071001000_2025.05.31.657160v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs137"},{"key":"2026041201071001000_2025.05.31.657160v1.12","doi-asserted-by":"crossref","unstructured":"Yu H , Li X-X , Han X , et al. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses. Front Microbiol 2023;14. Available at: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/10.3389\/fmicb.2023.1126808\/full [Accessed February 1, 2025].","DOI":"10.3389\/fmicb.2023.1126808"},{"key":"2026041201071001000_2025.05.31.657160v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00766-x"},{"key":"2026041201071001000_2025.05.31.657160v1.14","doi-asserted-by":"crossref","unstructured":"Li Z , Xiong W , Liang Z , et al. Critical role of the gut microbiota in immune responses and cancer immunotherapy. J Hematol Oncol 2024;17:33.","DOI":"10.1186\/s13045-024-01541-w"},{"key":"2026041201071001000_2025.05.31.657160v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40439-y"},{"key":"2026041201071001000_2025.05.31.657160v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42788-0"},{"key":"2026041201071001000_2025.05.31.657160v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329969"},{"key":"2026041201071001000_2025.05.31.657160v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00766-x"},{"key":"2026041201071001000_2025.05.31.657160v1.19","doi-asserted-by":"crossref","unstructured":"Zhao H , Wu L , Yan G , et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 2021;6:263.","DOI":"10.1038\/s41392-021-00658-5"},{"key":"2026041201071001000_2025.05.31.657160v1.20","unstructured":"Soundararajan R , Maurin MM , Rodriguez-Silva J , et al. Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. Gut 2024:gutjnl-2024-332535."},{"key":"2026041201071001000_2025.05.31.657160v1.21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009720"},{"key":"2026041201071001000_2025.05.31.657160v1.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050054"},{"key":"2026041201071001000_2025.05.31.657160v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz279"},{"key":"2026041201071001000_2025.05.31.657160v1.24","doi-asserted-by":"crossref","unstructured":"De Santis S , Verna G , Serino G , et al. Winnie-APC(Min\/+) Mice: A Spontaneous Model of Colitis-Associated Colorectal Cancer Combining Genetics and Inflammation. Int J Mol Sci 2020;21.","DOI":"10.3390\/ijms21082972"},{"key":"2026041201071001000_2025.05.31.657160v1.25","doi-asserted-by":"crossref","unstructured":"Kodani T , Rodriguez-Palacios A , Corridoni D , et al. Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system. Journal of visualized experiments : JoVE 2013:e50843.","DOI":"10.3791\/50843-v"},{"key":"2026041201071001000_2025.05.31.657160v1.26","doi-asserted-by":"crossref","unstructured":"Clum A , Huntemann M , Bushnell B , et al. DOE JGI Metagenome Workflow. mSystems 2021;6.","DOI":"10.1128\/mSystems.00804-20"},{"key":"2026041201071001000_2025.05.31.657160v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0176-y"},{"key":"2026041201071001000_2025.05.31.657160v1.28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm900"},{"key":"2026041201071001000_2025.05.31.657160v1.29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btn615"},{"key":"2026041201071001000_2025.05.31.657160v1.30","first-page":"1673","article-title":"Development and application of a fast ultra-high performance liquid chromatography-trapped ion mobility mass spectrometry method for untargeted lipidomics","volume":"463124","year":"2022","journal-title":"Journal of Chromatography A"},{"key":"2026041201071001000_2025.05.31.657160v1.31","doi-asserted-by":"crossref","unstructured":"Carbone D , Vestuto V , Ferraro MR , et al. Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification. Eur J Med Chem 2022;234:114233.","DOI":"10.1016\/j.ejmech.2022.114233"},{"key":"2026041201071001000_2025.05.31.657160v1.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-023-05084-w"},{"key":"2026041201071001000_2025.05.31.657160v1.33","doi-asserted-by":"crossref","unstructured":"Caponigro V , Tornesello AL , Merciai F , et al. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients. Journal of Translational Medicine 2023;21:918.","DOI":"10.1186\/s12967-023-04801-4"},{"key":"2026041201071001000_2025.05.31.657160v1.34","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16496"},{"key":"2026041201071001000_2025.05.31.657160v1.35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084461"},{"key":"2026041201071001000_2025.05.31.657160v1.36","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-015-0046-y"},{"key":"2026041201071001000_2025.05.31.657160v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab102"},{"key":"2026041201071001000_2025.05.31.657160v1.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01386.x"},{"key":"2026041201071001000_2025.05.31.657160v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0280-2"},{"key":"2026041201071001000_2025.05.31.657160v1.40","doi-asserted-by":"crossref","unstructured":"Sun Q , Wu J , Zhu G , et al. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. Front Endocrinol 2023;13. Available at: https:\/\/www.frontiersin.org\/journals\/endocrinology\/articles\/10.3389\/fendo.2022.1089918\/full [Accessed May 16, 2025].","DOI":"10.3389\/fendo.2022.1089918"},{"key":"2026041201071001000_2025.05.31.657160v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0649-5"},{"key":"2026041201071001000_2025.05.31.657160v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45636-x"},{"key":"2026041201071001000_2025.05.31.657160v1.43","doi-asserted-by":"crossref","unstructured":"Yang J , Ren H , Cao J , et al. Gut commensal Lachnospiraceae bacteria contribute to anti-colitis effects of Lactiplantibacillus plantarum exopolysaccharides. International Journal of Biological Macromolecules 2025;309:142815.","DOI":"10.1016\/j.ijbiomac.2025.142815"},{"key":"2026041201071001000_2025.05.31.657160v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac182"},{"key":"2026041201071001000_2025.05.31.657160v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00784-7"},{"key":"2026041201071001000_2025.05.31.657160v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01259-6"},{"key":"2026041201071001000_2025.05.31.657160v1.47","doi-asserted-by":"crossref","unstructured":"Telleria O , Alboniga OE , Clos-Garcia M , et al. A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients. Metabolites 2022;12:550.","DOI":"10.3390\/metabo12060550"},{"key":"2026041201071001000_2025.05.31.657160v1.48","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1202-9"},{"key":"2026041201071001000_2025.05.31.657160v1.49","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.96"},{"key":"2026041201071001000_2025.05.31.657160v1.50","doi-asserted-by":"publisher","DOI":"10.1006\/anae.2001.0376"},{"key":"2026041201071001000_2025.05.31.657160v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0012-9"},{"key":"2026041201071001000_2025.05.31.657160v1.52","doi-asserted-by":"crossref","unstructured":"Wang D , Zhu L , Liu H , et al. Altered gut metabolites and metabolic reprogramming involved in the pathogenesis of colitis-associated colorectal cancer and the transition of colon \u201cinflammation to cancer.\u201d J Pharm Biomed Anal 2025;253:116553.","DOI":"10.1016\/j.jpba.2024.116553"},{"key":"2026041201071001000_2025.05.31.657160v1.53","doi-asserted-by":"crossref","unstructured":"Fu J , Li G , Li X , et al. Gut commensal Alistipes as a potential pathogenic factor in colorectal cancer. Discov Onc 2024;15:473.","DOI":"10.1007\/s12672-024-01393-3"},{"key":"2026041201071001000_2025.05.31.657160v1.54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.08.003"},{"key":"2026041201071001000_2025.05.31.657160v1.55","doi-asserted-by":"crossref","unstructured":"Dadgar-Zankbar L , Shariati A , Bostanghadiri N , et al. Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer. Infectious Agents and Cancer 2023;18:48.","DOI":"10.1186\/s13027-023-00523-w"},{"key":"2026041201071001000_2025.05.31.657160v1.56","doi-asserted-by":"crossref","unstructured":"Liu J , Huang X , Chen C , et al. Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction. Journal of Translational Medicine 2023;21:373.","DOI":"10.1186\/s12967-023-04119-1"},{"key":"2026041201071001000_2025.05.31.657160v1.57","doi-asserted-by":"publisher","DOI":"10.23922\/jarc.2024-014"},{"key":"2026041201071001000_2025.05.31.657160v1.58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2413241121"},{"key":"2026041201071001000_2025.05.31.657160v1.59","doi-asserted-by":"crossref","unstructured":"Chuandong Z , Hu J , Li J , et al. Distribution and roles of Ligilactobacillus murinus in hosts. Microbiological Research 2024;282:127648.","DOI":"10.1016\/j.micres.2024.127648"},{"key":"2026041201071001000_2025.05.31.657160v1.60","doi-asserted-by":"crossref","unstructured":"Chang CS , Liao YC , Huang CT , et al. Identification of a gut microbiota member that ameliorates DSS-induced colitis in intestinal barrier enhanced Dusp6-deficient mice. Cell Rep 2021;37:110016.","DOI":"10.1016\/j.celrep.2021.110016"},{"key":"2026041201071001000_2025.05.31.657160v1.61","doi-asserted-by":"crossref","unstructured":"Kim SW , Ha YJ , Bang KH , et al. Potential of Bacteriocins from Lactobacillus taiwanensis for Producing Bacterial Ghosts as a Next Generation Vaccine. Toxins (Basel) 2020;12.","DOI":"10.3390\/toxins12070432"},{"key":"2026041201071001000_2025.05.31.657160v1.62","doi-asserted-by":"publisher","DOI":"10.7150\/jca.63578"},{"key":"2026041201071001000_2025.05.31.657160v1.63","doi-asserted-by":"crossref","unstructured":"Achasova KM , Snytnikova OA , Chanushkina KE , et al. Baseline abundance of Akkermansia muciniphila and Bacteroides acidifaciens in a healthy state predicts inflammation associated tumorigenesis in the AOM\/DSS mouse model. Sci Rep 2025;15:12241.","DOI":"10.1038\/s41598-025-96514-5"},{"key":"2026041201071001000_2025.05.31.657160v1.64","first-page":"1","volume":"8","year":"2024","journal-title":"Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer. npj Precis Onc"},{"key":"2026041201071001000_2025.05.31.657160v1.65","doi-asserted-by":"crossref","unstructured":"Yu H , Li X-X , Han X , et al. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses. Front Microbiol 2023;14:1126808.","DOI":"10.3389\/fmicb.2023.1126808"},{"key":"2026041201071001000_2025.05.31.657160v1.66","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac284"},{"key":"2026041201071001000_2025.05.31.657160v1.67","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae061"},{"key":"2026041201071001000_2025.05.31.657160v1.68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1082835"},{"key":"2026041201071001000_2025.05.31.657160v1.69","doi-asserted-by":"crossref","unstructured":"Nobels A , Marcke C van, Jordan BF , et al. The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab 2025:1\u201323.","DOI":"10.1038\/s42255-025-01287-w"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.05.31.657160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:03:01Z","timestamp":1782277381000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.05.31.657160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1101\/2025.05.31.657160","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1172\/JCI196712","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,6,3]]},"subtype":"preprint"}}